607 related articles for article (PubMed ID: 25223790)
1. Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers.
Gao X; Tsang JC; Gaba F; Wu D; Lu L; Liu P
Nucleic Acids Res; 2014 Nov; 42(20):e155. PubMed ID: 25223790
[TBL] [Abstract][Full Text] [Related]
2. Reprogramming to pluripotency using designer TALE transcription factors targeting enhancers.
Gao X; Yang J; Tsang JC; Ooi J; Wu D; Liu P
Stem Cell Reports; 2013; 1(2):183-97. PubMed ID: 24052952
[TBL] [Abstract][Full Text] [Related]
3. Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors.
Hu J; Lei Y; Wong WK; Liu S; Lee KC; He X; You W; Zhou R; Guo JT; Chen X; Peng X; Sun H; Huang H; Zhao H; Feng B
Nucleic Acids Res; 2014 Apr; 42(7):4375-90. PubMed ID: 24500196
[TBL] [Abstract][Full Text] [Related]
4. RNA-guided transcriptional regulation in planta via synthetic dCas9-based transcription factors.
Piatek A; Ali Z; Baazim H; Li L; Abulfaraj A; Al-Shareef S; Aouida M; Mahfouz MM
Plant Biotechnol J; 2015 May; 13(4):578-89. PubMed ID: 25400128
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Based Chromatin Remodeling of the Endogenous Oct4 or Sox2 Locus Enables Reprogramming to Pluripotency.
Liu P; Chen M; Liu Y; Qi LS; Ding S
Cell Stem Cell; 2018 Feb; 22(2):252-261.e4. PubMed ID: 29358044
[TBL] [Abstract][Full Text] [Related]
6. Ash2l interacts with Oct4-stemness circuitry to promote super-enhancer-driven pluripotency network.
Tsai PH; Chien Y; Wang ML; Hsu CH; Laurent B; Chou SJ; Chang WC; Chien CS; Li HY; Lee HC; Huo TI; Hung JH; Chen CH; Chiou SH
Nucleic Acids Res; 2019 Nov; 47(19):10115-10133. PubMed ID: 31555818
[TBL] [Abstract][Full Text] [Related]
7. Applications of Engineered DNA-Binding Molecules Such as TAL Proteins and the CRISPR/Cas System in Biology Research.
Fujita T; Fujii H
Int J Mol Sci; 2015 Sep; 16(10):23143-64. PubMed ID: 26404236
[TBL] [Abstract][Full Text] [Related]
8. RNA-Guided Activation of Pluripotency Genes in Human Fibroblasts.
Xiong K; Zhou Y; Blichfeld KA; Hyttel P; Bolund L; Freude KK; Luo Y
Cell Reprogram; 2017 Jun; 19(3):189-198. PubMed ID: 28557624
[TBL] [Abstract][Full Text] [Related]
9. Gene transcription repression in Clostridium beijerinckii using CRISPR-dCas9.
Wang Y; Zhang ZT; Seo SO; Lynn P; Lu T; Jin YS; Blaschek HP
Biotechnol Bioeng; 2016 Dec; 113(12):2739-2743. PubMed ID: 27240718
[TBL] [Abstract][Full Text] [Related]
10. Gene activation by a CRISPR-assisted
Xu X; Gao J; Dai W; Wang D; Wu J; Wang J
Elife; 2019 Apr; 8():. PubMed ID: 30973327
[TBL] [Abstract][Full Text] [Related]
11. Modularized CRISPR/dCas9 effector toolkit for target-specific gene regulation.
Agne M; Blank I; Emhardt AJ; Gäbelein CG; Gawlas F; Gillich N; Gonschorek P; Juretschke TJ; Krämer SD; Louis N; Müller A; Rudorf A; Schäfer LM; Scheidmann MC; Schmunk LJ; Schwenk PM; Stammnitz MR; Warmer PM; Weber W; Fischer A; Kaufmann B; Wagner HJ; Radziwill G
ACS Synth Biol; 2014 Dec; 3(12):986-9. PubMed ID: 25524106
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional reprogramming in yeast using dCas9 and combinatorial gRNA strategies.
Jensen ED; Ferreira R; Jakočiūnas T; Arsovska D; Zhang J; Ding L; Smith JD; David F; Nielsen J; Jensen MK; Keasling JD
Microb Cell Fact; 2017 Mar; 16(1):46. PubMed ID: 28298224
[TBL] [Abstract][Full Text] [Related]
13. Benchmarking of TALE- and CRISPR/dCas9-Based Transcriptional Regulators in Mammalian Cells for the Construction of Synthetic Genetic Circuits.
Lebar T; Jerala R
ACS Synth Biol; 2016 Oct; 5(10):1050-1058. PubMed ID: 27344932
[TBL] [Abstract][Full Text] [Related]
14. Intrinsic activation of cardiosphere-derived cells enhances myocardial repair.
Sano T; Ito T; Ishigami S; Bandaru S; Sano S
J Thorac Cardiovasc Surg; 2022 Apr; 163(4):1479-1490.e5. PubMed ID: 32682583
[TBL] [Abstract][Full Text] [Related]
15. RNA-guided transcriptional activation via CRISPR/dCas9 mimics overexpression phenotypes in Arabidopsis.
Park JJ; Dempewolf E; Zhang W; Wang ZY
PLoS One; 2017; 12(6):e0179410. PubMed ID: 28622347
[TBL] [Abstract][Full Text] [Related]
16. Functional Comparison between VP64-dCas9-VP64 and dCas9-VP192 CRISPR Activators in Human Embryonic Kidney Cells.
Javaid N; Pham TLH; Choi S
Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33401508
[TBL] [Abstract][Full Text] [Related]
17. Targeted transcriptional activation of silent oct4 pluripotency gene by combining designer TALEs and inhibition of epigenetic modifiers.
Bultmann S; Morbitzer R; Schmidt CS; Thanisch K; Spada F; Elsaesser J; Lahaye T; Leonhardt H
Nucleic Acids Res; 2012 Jul; 40(12):5368-77. PubMed ID: 22387464
[TBL] [Abstract][Full Text] [Related]
18. Multiplexed Transcriptional Activation or Repression in Plants Using CRISPR-dCas9-Based Systems.
Lowder LG; Paul JW; Qi Y
Methods Mol Biol; 2017; 1629():167-184. PubMed ID: 28623586
[TBL] [Abstract][Full Text] [Related]
19. Reversible Disruption of Specific Transcription Factor-DNA Interactions Using CRISPR/Cas9.
Shariati SA; Dominguez A; Xie S; Wernig M; Qi LS; Skotheim JM
Mol Cell; 2019 May; 74(3):622-633.e4. PubMed ID: 31051141
[TBL] [Abstract][Full Text] [Related]
20. Waking up dormant tumor suppressor genes with zinc fingers, TALEs and the CRISPR/dCas9 system.
Garcia-Bloj B; Moses C; Sgro A; Plani-Lam J; Arooj M; Duffy C; Thiruvengadam S; Sorolla A; Rashwan R; Mancera RL; Leisewitz A; Swift-Scanlan T; Corvalan AH; Blancafort P
Oncotarget; 2016 Sep; 7(37):60535-60554. PubMed ID: 27528034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
